Browse > Article

Evaluation on Immunogenicity and Safety of Avian Influenza Isolate(ADL0401) as a Candidate for the Killed Vaccine against tow-Pathogenic Avian Influenza  

Lee J. S. (College of Veterinary Medicine, Chungbuk National University)
Ha D. H. (College of Veterinary Medicine, Chungbuk National University)
Kim J. E. (College of Veterinary Medicine, Chungbuk National University)
Ha B. D. (College of Veterinary Medicine, Chungbuk National University)
Mo I. P. (College of Veterinary Medicine, Chungbuk National University)
Publication Information
Korean Journal of Poultry Science / v.32, no.2, 2005 , pp. 113-123 More about this Journal
Abstract
Avian influenza (AI) virus (AIV) is distributed worldwide and it has been isolated from various species of wild and domestic birds. AI transfers with high speed and shows diverse pathogenicity syndroms. In Korea, several low Pathogenic AIV, H9N2, have been isolated from the commercial farms with severe decrease of egg production and mortality resulted in severe economic loss since 1996. Therefore, it has been requested to develop AI vaccines to prevent clinical signs and economic losses from the field infection of AIV. To develop a killed vaccine that efficiently prevents low pathogenic AIV (H9N2), evaluation on the pathogenicity and selection of an inactivator for H9N2 is taking place and is being tested safety and immunogenicity of vaccine produced. Based on the pathogenicity test and viral reisolation test, the ADL0401 isolate is the characteristic low pathogenic AIVs and has fairly similar biologic functions compared with MS96 which is the official low pathogenic AIV (H9N2) and one of the predominant AIV isolated from poultry farms in Korea. In antigenicity tests, the ADL0401 and MS96 virus have no significant antigenic difference. In inactivation tests, the ADL0401 isolates can be easily inactivated with $0.1\%$ Formalin at $37^{\circ}C$ within 1 hour with a little decrease of HA titer. The vaccine developed in the present report has no harmful effect on bird and forms good immune capability. Therefore, the isolates, ADL0401 can be used for a killed vaccine which can reduce the clinical signs and viral shedding in the birds infected with H9N2 low pathogenic AIVs.
Keywords
low pathogenic avina influenza; pathogenicity; antigenicity; killed vaccine; immunogenicity; safety;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bano S, Naeem K, Malik SA 2003 Evaluation of pathogenic potential of avian influenza virus serotype H9N2 in chickens. Avian Dis 47:817-822   DOI   ScienceOn
2 Cadman HF, Kelly PJ, Zhou R, Davelaar F, Mason PR 1994 A broad-spectnnn avian influenza subtype antigen for indirect enzyme-linked immunosorbent assay for antibodies against poultry pathogens in ostriches (Struthio camelus) from Zimbabwe. Avian Dis 38:621-625   DOI   ScienceOn
3 Easterday BC, Hinshaw VS, Halvorson DA 1997 Influenza. In : Diseases of Poultry, 10th ed. Calnek BW, Barnes HJ, Beard CW, Mcdougald LR, Saif YM, eds. Iowa State University Press Ames IA, pp. 583-605
4 Kilbourne ED 1975 The influenza viruses and infection. An introduction. In : Kilbourne ED ed. The influenza viruses and influenza. Academic Press New York, pp 1-4
5 Krug RM, Lamb RA 2001 Orthomyxoviridae: The viruses and their replication. In: Field virology, 4th ed. Knipeand DM, Howlet PM, eds. Lippincott Williams and Wildins. Chapter 46, pp 1487-1532
6 Magill TP, Fransis T 1936 Jr Proc Soc Exp Biol and Med. 35:463
7 Nili H, Asasi K 2003 Avian influenza(H9N2) outbreak in Iran. Avian Dis 47:828-831   DOI   ScienceOn
8 Palese P, Young JF 1982 Variation of influenza A, B, and C viruses. Science 215 :1468-1474   DOI   PUBMED
9 World Health Organization Report 1973 Influenza neuraminidase and neuraminidase-inhibition test procedures. Bull WHO 48:199-203
10 Archetti I, Horsfall FL 1950 Persistent antigenic variation of influenza A viruses after incomplete neutralization in ova with heterologous immune serum. J Exp .Med 92:441-462   DOI   ScienceOn
11 David ES, Joan RB, Michael LP, Charles WB 2001 Efficasyof vaccine in chickens against highly pathogenic Hong Kong HSN1 avian influenza. Avian Dis 45:355-365   DOI   ScienceOn
12 Marandi MY, Bozorgmehrifard MH, Hashemzadeh M 1999 Efficacy of inactivated H9N2 avian influenza vaccine against non-highly pathogenic A/Chicken/Iran/ ZMT-101/98 infection
13 Skeeles JK, Beasley JN, Blore P, Klopp S 1981 Severe egg-production drops in turkey breeders in Southcentral Missouri. Avian Dis 25:764-767   DOI   ScienceOn
14 Hurst A 1957 Approaches to the chemotherapy of virus diseases. J Pharm Pharmacol 9:273-292   DOI
15 Alexander DJ, Gough RE 1986 Isolations of avian influenza virus from birds in Great Britain. Vet Rec 118:537-538   DOI   ScienceOn
16 Suarez DL, Senne DA 2000 Sequence analysis of related 10wpathogenic and highly pathogenic H5N2 avian influenza isolates from United States live bird markets and poultry farms from 1983 to 1989. Avian Dis 44:356-364   DOI   ScienceOn
17 Kawaoka Y, Webster RG 1988 Sequence requirement for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad Sci USA 85: 324-328   DOI   ScienceOn
18 Lee CW, S CS, L YJ, M IP 2000 Sequence analysis of the hemagglutinin gene of H9N2 Korean avian influenza viruses and assessment of the pathogenic potential of isolate MS96. Avian Dis 44:527-535   DOI   ScienceOn
19 Walker JA, Sakaguchi T, Matsuda Y, Yoshida T, Kawaoka Y 1992 Location and character of the cellular enzyme that cleavage the hemagglutinin of a virulent avian influenza virus. Virology 190(1):278-287   DOI   ScienceOn
20 Panigrahy B, Senne DA, Pearson JE 1995 Presence of avian influenza virus (AN) subtypes H5N2 and H7N1 in emus (Dromaius novaehollandiae) and rheas (Rhea americana) : Virus isolation and serologic findings. Avian Dis 39:64-67   DOI   ScienceOn
21 Shortridge KF, Zhou NN, Guan Y, Gao P, Ito T, Kawaoka Y, Kodihalli S, Krauss S, Markwell D, Murti KG, Norwood M, Senne D. Sims L. Takada A Webster RG 1998 Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 252:331-342   DOI   ScienceOn
22 Parsons GD, Alexander J, Manwell RJ 1986 Experimental assessment of the pathogenicity of eight influenza A viruses of N5 subtype for chickens, turkeys, ducks and quail. Avian Pathol 15:647-662   DOI
23 Horimoto T, Nakayama K, Smeekens SP, Kawaoka Y 1994 Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. J Virol 68(9):6074-6078
24 Liu M, Guan Y, Peiris M, He S, Webby RJ, Perez D, Webster RG 2003 The quest of influenza a viruses for new hosts. Avian Dis 47(3):849-856   DOI   ScienceOn
25 Cooley AJ, Campen GV, Philpott MS, Easterday BC, Hinshaw VS 1989. Pathological lesions in the lungs of ducks infected with influenza A viruses. Vet Pathol 26:1-5   DOI   ScienceOn
26 Tumpey TM, Suarez DL, Perkins LEL, Senne DA, Lee J, Lee YJ, Mo IP, Sung HW, Swayne DE 2003 Evaluation of a high-pahogenicity H5N1 avian influenza A virus isolated from duck meat. Avian Dis 47:951-955   DOI   ScienceOn
27 Xie Z, Stone HD 1990 Immune response to oil-emulsion vaccines with single or mixed antigens of newcastle disease, avian influenza and infectious bronchitis. Avian Dis 31: 154-162
28 Guan Y, Shortridge KF, Krauss S, Webster RG 1999 Molecularcharacterization of H9N2 influenza viruses : were they the donors of the 'internal' genes of HSNI viruses in Hong Kong? Proc Natl Acad Sci USA 96:9363-9367   DOI   ScienceOn
29 Barr PJ 1991 Mammalian Subtilisins : The longsought dibasic processing endoproteases. Cell 66(1): 1-3   DOI   PUBMED   ScienceOn
30 성환우 2003 공중보건 위생측면에서의 조류 인플루엔자 바 이러스 및 최근 국내 유행주의 특성.2003년 가금질병연구회 학술세미나, pp. 5-16
31 Woolcock MD, McFarland MD, Lai S, Chin RP 2001 Enhanced recovery of avian influenza virus isolates by a combination of chicken embryo inoculation methods. Avian Dis 45: 1030-1035   DOI   ScienceOn
32 Vey M, Orlich M, Adler S, Klenk GD, Rott R, Garten W 1992 Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition Motif R-X-K/R-R. Virology 188:408-413   DOI   ScienceOn
33 Guo YJ, Krauss S, Senne DA 2000 Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virology 267:279-288   DOI   ScienceOn
34 Stieneke-Grober A, Vey M, Ang1iker H, Shaw E, Thomas G, Robert C, Klenk lID, Garten W 1992 Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J 11(7):2407-2414
35 Lamb RA 1990 Orthomyxoviruses. In : Virology, Field BN, ed. Raven Press New York, pp 1091-1152